Changes in insulin sensitivity and secretion after sleeve gastrectomy
Open Access
- 20 January 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 103 (3) , 242-248
Abstract
Background: Sleeve gastrectomy is indicated for the treatment of obesity and related co-morbidity including diabetes. The dynamic changes in insulin secretion and sensitivity after sleeve gastrectomy are unknown. Methods: Whole-body insulin sensitivity was measured by the euglycaemic hyperinsulinaemic clamp technique, and insulin secretion by C-peptide deconvolution after an oral glucose tolerance test (OGTT), before and 3, 6 and 12 months after sleeve gastrectomy in morbidly obese subjects. The time course of glucagon-like peptide (GLP) 1, as a marker of insulin secretion following OGTT, was also assessed. Results: Ten patients were included in the study. Median (range) baseline insulin sensitivity (M-value) increased from 84·0 (20·2–131·4) mmol per kg per min at baseline to 122·8 (99·0–179·3) mmol per kg per min at 12 months after surgery (P = 0·015). Fasting insulin sensitivity, measured by homeostatic model assessment of insulin resistance, which represents a surrogate index of hepatic insulin resistance, decreased from 3·3 (1·9–5·5) to 0·7 (0·5–1·1) mg/dl·µunits/ml (P < 0·001). Total insulin secretion, measured as incremental area under the curve (AUC), after OGTT decreased from 360·4 (347·9–548·0) to 190·1 (10·1–252·0) mmol/l·180 min at 12 months (P = 0·011). The AUC for GLP-1 increased from 258·5 (97·5–552·6) to 5531·8 (4143·0–7540·9) pmol/l·180 min at 12 months after sleeve gastrectomy (P < 0·001). In multiple regression analysis, 51 per cent of the M-value variability was explained by GLP-1 secretion. Conclusion: Sleeve gastrectomy improved insulin sensitivity and reduced insulin secretion within 6 months after surgery. Although there was a correlation between insulin sensitivity and bodyweight, the major driver of the improvement in insulin sensitivity was GLP-1 secretion.Keywords
This publication has 38 references indexed in Scilit:
- Long-term remission of type 2 diabetes in morbidly obese patients after sleeve gastrectomySurgery for Obesity and Related Diseases, 2013
- Insulin Sensitivity and Secretion Changes After Gastric Bypass in Normotolerant and Diabetic Obese SubjectsAnnals of Surgery, 2013
- Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose toleranceAmerican Journal of Physiology-Endocrinology and Metabolism, 2012
- Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with DiabetesNew England Journal of Medicine, 2012
- Magnitude and Variability of the Glucagon-Like Peptide-1 Response in Patients With Type 2 Diabetes up to 2 Years Following Gastric Bypass SurgeryDiabetes Care, 2011
- Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetesSurgical Endoscopy, 2009
- First-Phase Insulin Secretion Restoration and Differential Response to Glucose Load Depending on the Route of Administration in Type 2 Diabetic Subjects After Bariatric SurgeryDiabetes Care, 2009
- Effect of Weight Loss by Gastric Bypass Surgery Versus Hypocaloric Diet on Glucose and Incretin Levels in Patients with Type 2 DiabetesThe Journal of Clinical Endocrinology & Metabolism, 2008
- Bariatric surgery: effects on glucose homeostasisCurrent Opinion in Clinical Nutrition and Metabolic Care, 2006
- Mechanisms of Recovery From Type 2 Diabetes After Malabsorptive Bariatric SurgeryDiabetes, 2006